Literature DB >> 27283762

Prevalence of pulmonary tuberculosis in western China in 2010-11: a population-based, cross-sectional survey.

Peierdun Mijiti1, Li Yuehua2, Xue Feng2, Paul J Milligan3, Corinne Merle4, Wu Gang5, Liu Nianqiang2, Halmurat Upur6.   

Abstract

BACKGROUND: Progress in tuberculosis control in China has been the slowest in western areas, which have the highest prevalence. We assessed the prevalence of pulmonary tuberculosis in the Xinjiang province, China, 10 years after introduction of a control programme based on directly observed treatment, short course.
METHODS: In this population-based, cross-sectional survey, we used a multistage stratified random cluster sample design to estimate the prevalence of smear-positive and bacteriologically confirmed (either smear positive or culture positive, or both) pulmonary tuberculosis among adults (aged ≥15 years) in Xinjiang who had been resident in their household for the last 6 months. The screening strategy and diagnosis followed WHO guidelines. We estimated prevalence by combining inverse probability weighting and multiple imputation of missing data. We compared our prevalence survey estimates with the ones from the 2010 China national pulmonary tuberculosis survey and the ones from a provincial pulmonary survey done in Xinjiang in 2000. The new smear-positive pulmonary tuberculosis notification rate in 2011 in Xinjiang was obtained to allow the calculation of patient diagnosis rate (PDR).
FINDINGS: Between Sept 1, 2010, and July 31, 2011, 31 081 individuals were eligible, of whom 29 835 (96·0%) participated in the survey. We identified 50 (0·2%) smear-positive and 101 (0·3%) bacteriologically confirmed pulmonary tuberculosis cases. The weighted prevalence of smear-positive pulmonary tuberculosis was 170 (95% CI 103-233) per 100 000 people and of bacteriologically confirmed pulmonary tuberculosis was 430 (249-611) per 100 000 people. Compared with 2000 Xinjiang survey estimates, the prevalence of smear-positive pulmonary tuberculosis has decreased by 26·4% (from 231 [95% CI 148-314] per 100 000 people), whereas the prevalence of bacteriologically confirmed pulmonary tuberculosis has increased by 17·8% (from 365 [237-493] per 100 000 people). In each age group and sex, the pulmonary tuberculosis prevalence was higher in the 2010-11 Xinjiang survey than in the 2010 national survey. The PDR in 2011 was 0·34 (95% CI 0·25-0·44).
INTERPRETATION: Despite progress in other parts of China, the prevalence of pulmonary tuberculosis in Xinjiang remains high. The very low PDR suggests poor access to diagnosis and care. Further studies are needed to understand the barriers to diagnosis and care of this population, and efforts are urgently needed to enhance tuberculosis screening in this area. FUNDING: Xinjiang Uyghur Autonomous Region Health Bureau.
Copyright © 2016 Mijiti et al. Open Access article distributed under the terms of CC BY-NC-ND. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27283762     DOI: 10.1016/S2214-109X(16)30074-2

Source DB:  PubMed          Journal:  Lancet Glob Health        ISSN: 2214-109X            Impact factor:   26.763


  13 in total

1.  Unbalanced Risk of Pulmonary Tuberculosis in China at the Subnational Scale: Spatiotemporal Analysis.

Authors:  Maogui Hu; Yuqing Feng; Tao Li; Yanlin Zhao; Jinfeng Wang; Chengdong Xu; Wei Chen
Journal:  JMIR Public Health Surveill       Date:  2022-07-01

2.  Cancer risk in tuberculosis patients in a high endemic area.

Authors:  Guang-Liang Chen; Li Guo; Shun'e Yang; Dong-Mei Ji
Journal:  BMC Cancer       Date:  2021-06-09       Impact factor: 4.430

3.  Improving tuberculosis case detection in underdeveloped multi-ethnic regions with high disease burden: a case study of integrated control program in China.

Authors:  Jun Li; Xiao-Qiu Liu; Shi-Wen Jiang; Xue Li; Fei Yu; Yan Wang; Yong Peng; Xiao-Ming Gu; Yan-Ni Sun; Hui Zhang; Li-Xia Wang
Journal:  Infect Dis Poverty       Date:  2017-11-29       Impact factor: 4.520

4.  Tuberculosis infection in rural labor migrants in Shenzhen, China: Emerging challenge to tuberculosis control during urbanization.

Authors:  Xiangwei Li; Qianting Yang; Boxuan Feng; Henan Xin; MingXia Zhang; Qunyi Deng; Guofang Deng; Wanshui Shan; Jianrong Yue; Haoran Zhang; Mufei Li; Hengjing Li; Qi Jin; Xinchun Chen; Lei Gao
Journal:  Sci Rep       Date:  2017-06-30       Impact factor: 4.379

5.  Burden of tuberculosis in Xinjiang between 2011 and 2015: A surveillance data-based study.

Authors:  Xiangyan He; Mingqin Cao; Tanmay Mahapatra; Xiangpin Du; Sanchita Mahapatra; Qifeng Li; Lei Feng; Songyuan Tang; Zhen Zhao; Jinbao Liu; Weiming Tang
Journal:  PLoS One       Date:  2017-11-09       Impact factor: 3.240

6.  Epidemiological characteristics of pulmonary tuberculosis among children in Shandong, China, 2005-2017.

Authors:  Ning-Ning Tao; Yi-Fan Li; Yun-Xia Liu; Jin-Yue Liu; Wan-Mei Song; Yao Liu; Hong Geng; Shan-Shan Wang; Huai-Chen Li
Journal:  BMC Infect Dis       Date:  2019-05-10       Impact factor: 3.090

7.  Epidemiological characteristics of pulmonary tuberculosis in Shandong, China, 2005-2017: A retrospective study.

Authors:  Ning-Ning Tao; Yi-Fan Li; Shan-Shan Wang; Yun-Xia Liu; Jin-Yue Liu; Wan-Mei Song; Yao Liu; Hong Geng; Huai-Chen Li
Journal:  Medicine (Baltimore)       Date:  2019-05       Impact factor: 1.817

8.  Application Value of SAT-TB Combined with Acid-Fast Staining in the Diagnosis and Treatment of Pulmonary Tuberculosis.

Authors:  Chaochao Qiu; Ning Pan; Yueying Zhou; Hongye Ning; Xinchun Ye; Saiduo Liu; Jichan Shi
Journal:  Biomed Res Int       Date:  2020-11-03       Impact factor: 3.411

9.  Cash transfers to enhance TB control: lessons from the HIV response.

Authors:  William E Rudgard; Daniel J Carter; James Scuffell; Lucie D Cluver; Nicole Fraser-Hurt; Delia Boccia
Journal:  BMC Public Health       Date:  2018-08-22       Impact factor: 3.295

10.  The association between internal migration and pulmonary tuberculosis in China, 2005-2015: a spatial analysis.

Authors:  Wei-Bin Liao; Ke Ju; Ya-Min Gao; Jay Pan
Journal:  Infect Dis Poverty       Date:  2020-02-17       Impact factor: 4.520

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.